FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

ULTRAGENYX PHARMACEUTICAL INC.: revenue

One fact, its scope and the complete path back to the official record.

Period: 2024-01-01 – 2024-12-31Status: supersededProvenance attached

Cite: FACTANKER, https://factanker.com/fact/2f6411f7-033a-4a14-8cfc-93ab8f12a1df

Reported value

$560.230M{"amount": 560230000, "concept": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "currency": "USD"}
Entity
ULTRAGENYX PHARMACEUTICAL INC.
Metric
revenue
Period
2024-01-01 – 2024-12-31
Status
superseded
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0000950170-25-023312 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T15:13:48.701378+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001515673/revenue/2024-12-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.